Here, we report that RAR-β expression is reduced in pancreatic ductal adenocarcinoma (PDAC) and its downregulation correlates with tumour stage, pointing towards RAR-β as an interesting target in PDAC. The gene discussed is RARB; the disease is pancreatic ductal adenocarcinoma.